Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Falk W Lohoff

Showing results (1-10 of 134) with videos related to

Pageof 14
Sort By:
Frontiers in Psychiatry|June 27, 2022
Targeting Unmet Clinical Needs in the Treatment of Alcohol Use DisorderFalk W Lohoff
Current Psychiatry Reports|September 18, 2010
Overview of the genetics of major depressive disorderFalk W Lohoff
Pharmacogenomics|August 19, 2020
Pharmacotherapies and personalized medicine for alcohol use disorder: a reviewFalk W Lohoff
Methods in Molecular Biology (Clifton, N.J.)|April 27, 2010
Genetic variants in the vesicular monoamine transporter 1 (VMAT1/SLC18A1) and neuropsychiatric disordersFalk W Lohoff
Pharmacogenomics|March 3, 2012
Pharmacogenetics of antidepressant drugs: current clinical practice and future directionsSneha Narasimhan, Falk W Lohoff
Expert Opinion on Pharmacotherapy|August 2, 2008
Desvenlafaxine succinate for the treatment of major depressive disorderFalk W Lohoff, Karl Rickels
Expert Opinion on Pharmacotherapy|January 28, 2010
Pharmacogenetic considerations in the treatment of psychiatric disordersFalk W Lohoff, Thomas N Ferraro
Psychiatry Research|October 13, 2015
Pharmacogenetics of alcohol use disorders and comorbid psychiatric disordersSarah G Helton, Falk W Lohoff
Frontiers in Neuroscience|June 30, 2020
Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) in the Brain and Relevance for Neuropsychiatric DisordersEmma M O'Connell, Falk W Lohoff
Psychiatric Genetics|November 30, 2005
Lack of association between variations in the melanocortin 5 receptor gene and bipolar disorderFalk W Lohoff, Wade H Berrettini
Pageof 14

Showing results (1-10 of 134) with videos related to

Sort By:
Pageof 14
Frontiers in Psychiatry|June 27, 2022
Targeting Unmet Clinical Needs in the Treatment of Alcohol Use DisorderFalk W Lohoff
Current Psychiatry Reports|September 18, 2010
Overview of the genetics of major depressive disorderFalk W Lohoff
Pharmacogenomics|August 19, 2020
Pharmacotherapies and personalized medicine for alcohol use disorder: a reviewFalk W Lohoff
Methods in Molecular Biology (Clifton, N.J.)|April 27, 2010
Genetic variants in the vesicular monoamine transporter 1 (VMAT1/SLC18A1) and neuropsychiatric disordersFalk W Lohoff
Pharmacogenomics|March 3, 2012
Pharmacogenetics of antidepressant drugs: current clinical practice and future directionsSneha Narasimhan, Falk W Lohoff
Expert Opinion on Pharmacotherapy|August 2, 2008
Desvenlafaxine succinate for the treatment of major depressive disorderFalk W Lohoff, Karl Rickels
Expert Opinion on Pharmacotherapy|January 28, 2010
Pharmacogenetic considerations in the treatment of psychiatric disordersFalk W Lohoff, Thomas N Ferraro
Psychiatry Research|October 13, 2015
Pharmacogenetics of alcohol use disorders and comorbid psychiatric disordersSarah G Helton, Falk W Lohoff
Frontiers in Neuroscience|June 30, 2020
Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) in the Brain and Relevance for Neuropsychiatric DisordersEmma M O'Connell, Falk W Lohoff
Psychiatric Genetics|November 30, 2005
Lack of association between variations in the melanocortin 5 receptor gene and bipolar disorderFalk W Lohoff, Wade H Berrettini
Pageof 14